Errata


In the November/December 2002 issue, in the article “Cancer Statistics for African Americans” (Ghafoor A, Jemal A, Cokkinides V, et al. CA Cancer J Clin 2002:52;326–341), an error appeared in the data for Tables 2 and 3 (pages 330 and 331, respectively). Table 2 and Table 3 have been modified with the corrected data and are reproduced here. We apologize for these errors and any confusion they may have caused.

Table TABLE 2. African American to White Incidence Rate Ratios, US, 1995 to 1999*
MalesFemales
Cancer Type†African AmericanWhiteAfrican American/WhiteCancer Type†African AmericanWhiteAfrican American/White
 RateRateRatio RateRateRatio
  1. *Rates are per 100,000 and age adjusted to the 2000 US standard population.

  2. †Site selected if cases greater than 100.

  3. Source: Surveillance, Epidemiology, and End Results program, Division of Cancer Control and Population Sciences, National Cancer Institute, 2002.

Myeloma13.16.52.0Myeloma10.34.22.5
Stomach19.310.71.8Stomach10.34.62.2
Esophagus12.87.61.7Esophagus4.42.02.2
Larynx12.27.11.7Small Intestine2.91.51.9
Prostate266.8163.21.6Larynx2.91.61.8
Liver and   Uterine Cervix13.68.11.7
Intrahepatic Bile Duct10.36.41.6Pancreas15.29.51.6
Lung and Bronchus125.684.41.5Liver and Intrahepatic Bile Duct4.02.51.6
Pancreas18.212.31.5    
Oral Cavity and Pharynx21.816.51.3Kidney and Renal Pelvis9.87.81.3
Kidney and Renal Pelvis18.415.61.2Colon and Rectum56.147.11.2
Colon and Rectum69.065.01.1Soft Tissue (including heart)2.62.41.1
Non-Hodgkin's   Lung and Bronchus54.453.31.0
Lymphoma19.924.50.8Breast123.7140.90.9
Leukemia12.616.70.8Urinary Bladder7.710.20.8
Myeloid Leukemia5.76.90.8Leukemia7.69.80.8
Acute Myeloid Leukemia3.44.50.8Uterine Corpus17.326.10.7
Hodgkin's Lymphoma2.73.40.8Hodgkin's Lymphoma2.02.80.7
Lymphocytic Leukemia5.37.40.7Ovary12.018.10.7
Chronic Lymphocytic   Non-Hodgkin's   
Leukemia4.15.50.7Lymphoma11.216.50.7
Brain4.68.30.6Thyroid5.610.00.6
Urinary Bladder19.339.80.5    
All Cancers695.3560.11.2All Cancers412.9433.51.0
Table TABLE 3. African American to White Mortality Rate Ratios, US, 1995 to 1999*
MalesFemales
Cancer Type†African AmericanWhiteAfrican American/WhiteCancer Type†African AmericanWhiteAfrican American/White
 RateRate RatioRateRateRatio
  1. *Rates are per 100,000 and age adjusted to the 2000 US standard population.

  2. †Site selected if number of deaths is greater than 100.

  3. Source: Underlying mortality data provided by the National Center for Health Statistics. Available at: http://www.cdc.gov/nchs.

Larynx5.82.42.4Stomach6.83.02.3
Prostate72.831.22.3Myeloma6.83.02.3
Stomach14.26.32.3Uterine Cervix6.22.82.2
Myeloma9.24.52.0Esophagus3.51.72.1
Oral Cavity and Pharynx8.34.22.0Larynx0.90.51.8
Esophagus12.97.21.8Uterine Corpus3.22.01.6
Liver and   Soft Tissue   
Liver and Intrahepatic Bile Duct9.25.91.6Soft Tissue (including heart)1.91.31.5
Lung and Bronchus109.179.71.4Colon and Rectum25.418.01.4
Pancreas16.212.01.4Pancreas13.09.01.4
Small Intestine0.50.71.4Liver and   
Colon and Rectum34.425.81.3Intrahepatic Bile Duct3.92.81.4
Kidney and   Breast37.128.21.3
Kidney and Renal Pelvis6.26.21.0Urinary Bladder3.12.31.3
Leukemia9.310.60.9Lung and Bronchus40.241.71.0
Hodgkin's Lymphoma0.70.71.0Kidney and Renal Pelvis2.92.91.0
Lymphocytic Leukemia3.03.30.9Leukemia5.66.10.9
Myeloid Leukemia3.74.50.8Myeloid Leukemia2.52.80.9
Non-Hodgkin's Lymphoma7.811.20.7Ovary7.69.30.8
Urinary Bladder5.78.00.7Non-Hodgkin's Lymphoma4.77.50.6
Brain3.26.00.5Brain2.34.10.6
Melanoma0.54.40.1Melanoma0.52.10.2
All Cancers359.2253.01.4All Cancers203.5169.81.2

In the November/December 2002 issue, in the article “American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer” (Saslow D, Runowicz CD, Solomon D, et al. CA Cancer J Clin 2002:52;342–362), an error appeared in the author byline on page 342.

The byline should have read “Debbie Saslow, PhD; Carolyn D. Runowicz, MD (for the Work Group on Interval, Older Women, and Hysterectomy); Diane Solomon, MD (for the Work Group on Technologies); Anna-Barbara Moscicki, MD (for the When to Start Screening Work Group); Robert A. Smith, PhD; Harmon J. Eyre, MD; Carmel Cohen, MD (for the Gynecologic Cancer Advisory Group).”

We apologize for this error and any confusion it may have caused.

Ancillary